0
0
11/23/23 at 8:21am
Organization
Bqprime.com
Author
Pratiksha Thayil
33 words
0
Comments
There were violations of current good manufacturing practices regulations for finished pharmaceuticals, the letter said.
You are the first to view
https://www.bqprime.com/markets/cipla-shares-slips-7-after-us-fda-issues-warning-letter-for-pithampur-facility
Create an account
or login to join the discussion